Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By Chemotherapy
Status:
Terminated
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Antiemetic drugs, such as fosaprepitant dimeglumine, may help lessen or prevent
nausea and vomiting in patients treated with chemotherapy.
PURPOSE: This clinical trial is studying the side effects of fosaprepitant dimeglumine and to
see how well it works in treating patients with nausea and vomiting caused by chemotherapy.